The National Institute for Health and Care Excellence (NICE) does not recommend the agents for the treatment of atopic dermatitis.
Posted inTechnology News
NICE questions cost-effectiveness for Adtralza, Rinvoq and Cibinqo – Pharmaceutical Technology
